| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $563.7M | $505.6M | $426.6M |
| YoY Revenue Growth % | +11.5% | +18.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $132.1M | $135.5M | $106.0M |
| Operating Margin % | 23.4% | 26.8% | 24.8% |
| Net Income (GAAP) | $80.0M | $85.0M | $65.8M |
| EBITDA (Normalized) | $152.4M | $153.7M | $121.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.4M | $55.8M | $68.3M |
| Capital Expenditures (CapEx) | $25.4M | $22.8M | $19.2M |
| Free Cash Flow (FCF) | -$27.8M | $33.0M | $49.1M |
| FCF Margin % | -4.9% | 6.5% | 11.5% |
| Return on Invested Capital (ROIC %) | 37.8% | 37.3% | 7.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $266.9M | $277.2M | $417.1M |
| Total Stockholders' Equity | $84.0M | $87.1M | $855.6M |